 |

 |
 |
 |

 |
Future of Drugs 
The search for better, faster and more effective medicine
1/15/2001 |
 |
|
 |
Mapping the Genome 
A project that will transform medicine more than vaccines and antibiotics combined
7/03/2000 |
 |
|
 |
Future of Medicine 
Ring in the century of the gene
1/11/1999 |
|
|
Indicates premium content.
|
|
 |
 |
 |
 |
 |
 E-mail your letter to the editor
|
 |
 |
|
 |
 |
 |
 |
GEORGE STEINMETZ FOR TIME
W. French Anderson: Director of Gene Therapy Laboratories and professor of biochemistry and pediatrics at the U.S.C School of Medicine |
|
 |
| The Pioneers of Molecular Biology: W. French Anderson |
 |
 |
As an undergraduate, he asked the question at the heart of gene therapy
|
 |
 |

By Leon Jaroff |
|
 |
Posted Sunday, February 9, 2002; 10:31 a.m. EST
W. French Anderson was still a senior in high school when he heard that "some people in England" had figured out the structure of DNA and published their reportin the journal Nature. That journal was hard to come by in Tulsa, Okla., but Anderson persevered, and a few weeks later was excitedly reading and rereading the Watson and Crick paper.
"I marveled at it," says Anderson, "but I really didn't understand it. I had no idea, for example, what X-ray diffraction was." But he was a precocious student and he won a scholarship to Harvard, where he audited a graduate chemistry course given by John Edsall, an expert in proteins. At one of Edsall's 1958 seminars, a visiting British scientist was lecturing about efforts to determine the structure of the hemoglobin molecule, which transports oxygen in the bloodstream.
Suddenly a thought occurred to Anderson, the only undergraduate in attendance. He raised his hand, and blurted out the idea that spawned gene therapy: "If you know the structure of normal hemoglobin, you could certainly know the structure of sickle hemoglobin." And because both of those structures are produced by genes, he argued, "you have a normal gene that makes normal hemoglobin and a mutant gene that makes sickle hemoglobin." Why, he wondered, "couldn't you take the gene for the normal hemoglobin and give it to a patient with sickle cell anemia and cure the disease?"
The room fell silent. Looking at the student disdainfully"he bored a hole right through me," Anderson remembersthe lecturer admonished him: "This is a serious scientific meeting. Don't waste our time."
"I just shrank," Anderson says. "I felt like crawling under the table. As soon as this thing was over, I was going to try to just sneak out." But as he stood to go, he felt a hand on his shoulder. It was John Edsall, who had been sitting behind him.
"Interesting idea," said Edsall, and walked off. Anderson's humiliation evaporated. "By God," he thought, "if John Edsall thinks it's an interesting idea, then it's an interesting idea, and that's what I'm going to do." From that moment on," he says, "gene therapy was my obsession and my lifetime goal."
Anderson has kept his eye on that goal ever since. He won approval for and helped conduct the first human gene therapy trial in 1990, treating two young girls with an immune system disorder, and has since been involved in 18 different gene therapy trials. He founded and still edits the influential journal, Human Gene Therapy, and served as the discipline's leading spokesman when it suffered a series of setbacks, including the death of a young research subject three and a half years ago and the emergence last year of a leukemia-like illness in a patient treated for the so-called bubble-boy disease.
"Every powerful technology has a downside," says Anderson, "and there will be setbacks along the way." Gene therapy clearly has more pitfalls than he had anticipated, but he is confident it will shake off its growing pains and play a major role in 21st century medicine.
|
|
 |
 |
 |

The Future of Life
Browse books, including Watson's autobiography, hand-picked by TIME editors
|
 |
|
 |
 |
 |
|
 |
 |
 |

NATION
Countdown to War
Inside Bush's all-out plan to convince the American public and the Security Council that Saddam must go
WORLD
Blix to Baghdad: I'm Listening...
UN weapons inspectors warn that unless Iraq changes its attitude, their report may prompt the Security Council to vote for war
|
|
SPORTS
The NBA's Center of Attention
Yao Ming is 22, an All-Star, the future of the Houston Rockets, the savior of the NBA and American business's most promising link to China. He's also very, very tall
PHOTO ESSAY
The Burden of Proof
George W. Bush turns up the heat on Saddam Hussein and prepares the country for possible war
|
|
|
|
|
 |
 |


|
 |